ribavirin has been researched along with Arthritis, Psoriatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behrendt, P; Brown, RJ; Dammermann, W; Drave, S; Iking-Konert, C; Lüth, S; Pischke, S; Schnoor, U; Steinmann, E; Todt, D; Wedemeyer, H | 1 |
| Mederacke, I; Meyer-Olson, D; Wedemeyer, H; Witte, T | 1 |
2 other study(ies) available for ribavirin and Arthritis, Psoriatic
| Article | Year |
|---|---|
Exacerbation of hepatitis E virus infection during anti-TNFα treatment.
Topics: Aged; Antirheumatic Agents; Antiviral Agents; Arthritis, Psoriatic; Etanercept; Hepatitis E; Hepatitis, Chronic; Humans; Immunocompromised Host; Male; Ribavirin; Tumor Necrosis Factor-alpha | 2017 |
Successful clearance of hepatitis C virus with pegylated interferon α-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis.
Topics: Adult; Antiviral Agents; Arthritis, Psoriatic; Drug Therapy, Combination; Etanercept; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunoglobulin G; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Latent Tuberculosis; Male; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Ribavirin | 2011 |